Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Muhyi Al‐Sarraf, Michael LeBlanc, Padmini Giri et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Medicine, Oncology, Radiation Oncology +13

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Ying Sun, Wen-Fei Li, Nian-Yong Chen et al. · The Lancet Oncology · 2016 · 950 citations

Medicine, Oncology, Radiation Oncology +14

Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

Joseph Wee, Eng Huat Tan, Bee Choo Tai et al. · Journal of Clinical Oncology · 2005 · 652 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

Lei Chen, Chaosu Hu, Xiao-Zhong Chen et al. · The Lancet Oncology · 2011 · 564 citations

Medicine, Oncology, Radiation Oncology +14

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong et al. · The Lancet · 2016 · 525 citations

Medicine, Oncology, Chemotherapy +11